🧵The 2026 ACC/AHA Dyslipidemia Guidelines are officially out!
These new updates bring major shifts in risk assessment, novel lipid markers, and cholesterol targets.
Open access 🔓
https://t.co/NYwsuLQYYz
Here are the most salient features you need to know.👇
Meta-analysis of four randomized trials found β-blockers did not reduce mortality, recurrent #MyocardialInfarction (MI), heart failure, or revascularization in patients with preserved left ventricular ejection fraction after MI. https://t.co/7Kht1Pi1QE
Meta-analysis of four randomized trials found β-blockers did not reduce mortality, recurrent #MyocardialInfarction (MI), heart failure, or revascularization in patients with preserved left ventricular ejection fraction after MI. https://t.co/7Kht1Pi1QE
Withdrawal of heart failure therapy after atrial fibrillation rhythm control with ejection fraction normalization: the WITHDRAW-AF trial https://t.co/MyFxT5VxcX
The harmful and biased medical advice from social medial influencers, highlighting lack of expertise, and financial conflicts. Many specific examples and recommendations provided @bmj_latest
https://t.co/zFjaqQvi9O
Today, @WHO published a guideline in JAMA on the use and indications of #GLP1 therapies, including GLP-1 receptor agonists and GLP-1/GIP dual agonists, for the global treatment of #obesity in adults. https://t.co/mgaUmJUUxy 🧵
Over the past two decades, the risk of stroke in atrial fibrillation patients decreased significantly among all age groups, with no subsequent increase in the risk of bleeding.
Read more in #EHJ@escardio@ESC_Journals#atrialfibrillation
https://t.co/rAhd2bBlTH
Cellular and molecular imaging of coronary atherosclerosis: clinical applications. A State-of-the-Art review just published in #EHJ 👉 https://t.co/iElnGXCyIN
@RoccoMontone@ehj_ed
In older patients with myocardial infarction and multivessel disease, physiology-guided complete revascularization achieved a sustained reduction in adverse outcomes compared to culprit-only treatment over a 3-year follow-up period. https://t.co/kZUI2Dl9G4
New blood pressure guidelines from @American_Heart and @ACCinTouch emphasize earlier treatment and tighter control.
Learn what’s new—and what remains unchanged—in the latest recommendations. #hypertension
https://t.co/PquihlJv2D
🧵A Fellow’s Guide to Impella
MCS can feel like alphabet soup: IABP, Impella CP/5.5, ECMO, RP Flex, Tandem. But behind the wires and waveforms is a real framework.
Here’s a breakdown from a phenomenal teaching session by @QuanBuiMD#UCSDlifer
Enjoyed and learnt every minute at @cvinnovations CVI2025. Thanks to course directors Drs. Subhash Banerjee, @esbrilakis@psorajja@shishem for organizing such a fantastic conference. Great work by @vjainmd presenting our challenging case.
Looking forward to attending again next year!